Purpose Unlimited Inc’s AbbVie ABBV Stock Holding History

Purpose Unlimited Inc’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$190K	Hold	754	–	–	0.01%	248
2026 Q1	$164K	Hold	754	–	–	0.01%	258
2025 Q4	$172K	Buy	+754	New	+$172K	0.01%	191

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Purpose Unlimited Inc's ABBV Position: Q2 2026 in Review

Purpose Unlimited Inc held its AbbVie (ABBV) position steady in Q2 2026 at 754 shares worth $190K. The position accounts for 0.01% of the portfolio, ranked #248.

Purpose Unlimited Inc first reported a position in ABBV in Q4 2025 and has held it in 3 quarters since. 4,231 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Purpose Unlimited Inc held 754 shares of AbbVie worth $190K as of Q2 2026.
Purpose Unlimited Inc left its AbbVie share count unchanged in Q2 2026.
AbbVie made up 0.01% of Purpose Unlimited Inc's portfolio in Q2 2026, its #248 holding.
Purpose Unlimited Inc first reported a position in AbbVie in Q4 2025 and has held it in 3 quarters since.
4,231 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Purpose Unlimited Inc's 13F filing for Q2 2026, filed 13 Aug 2026.